KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molina Healthcare (MOH) Total Current Liabilities (2016 - 2025)

Molina Healthcare's Total Current Liabilities history spans 16 years, with the latest figure at $7.5 billion for Q3 2025.

  • For Q3 2025, Total Current Liabilities fell 10.27% year-over-year to $7.5 billion; the TTM value through Sep 2025 reached $7.5 billion, down 10.27%, while the annual FY2024 figure was $7.9 billion, 3.33% down from the prior year.
  • Total Current Liabilities for Q3 2025 was $7.5 billion at Molina Healthcare, down from $7.9 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $8.5 billion in Q1 2024 and bottomed at $5.3 billion in Q1 2021.
  • The 5-year median for Total Current Liabilities is $7.5 billion (2023), against an average of $7.4 billion.
  • The largest annual shift saw Total Current Liabilities skyrocketed 70.7% in 2021 before it fell 10.27% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $7.0 billion in 2021, then fell by 2.72% to $6.9 billion in 2022, then rose by 19.15% to $8.2 billion in 2023, then decreased by 3.33% to $7.9 billion in 2024, then fell by 5.26% to $7.5 billion in 2025.
  • Per Business Quant, the three most recent readings for MOH's Total Current Liabilities are $7.5 billion (Q3 2025), $7.9 billion (Q2 2025), and $8.2 billion (Q1 2025).